37 related articles for article (PubMed ID: 22997098)
1. Proteomic mapping of stimulus-specific signaling pathways involved in THP-1 cells exposed to Porphyromonas gingivalis or its purified components.
Saba JA; McComb ME; Potts DL; Costello CE; Amar S
J Proteome Res; 2007 Jun; 6(6):2211-21. PubMed ID: 17477557
[TBL] [Abstract][Full Text] [Related]
2. ENO1 promotes trophoblast invasion regulated by E2F8 in recurrent miscarriage.
Liu Z; Wang C; Tang Y; Zhang X; Pei J; Liu H; Yu Y; Gu W
FASEB J; 2024 Apr; 38(8):e23631. PubMed ID: 38661062
[TBL] [Abstract][Full Text] [Related]
3. Proteomics in nasopharyngeal carcinoma.
Li F; Guan Y; Chen Z
Cell Mol Life Sci; 2008 Apr; 65(7-8):1007-12. PubMed ID: 18213447
[No Abstract] [Full Text] [Related]
4. Correlations of Expression Levels of Lung Cancer Marker Gene Eno2 and Genes of Carcinogenesis and Apoptosis in the Hypothalamus of Mice with Depression-Like Behavior.
Galyamina AG; Kovalenko IL; Smagin DA; Kudryavtseva NN
Bull Exp Biol Med; 2024 Mar; 176(5):612-616. PubMed ID: 38730106
[TBL] [Abstract][Full Text] [Related]
5. Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.
Yarza R; Bover M; Agulló-Ortuño MT; Iglesias-Docampo LC
J Exp Clin Cancer Res; 2021 Jun; 40(1):202. PubMed ID: 34154654
[TBL] [Abstract][Full Text] [Related]
6. VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.
Ning Y; Zeng Z; Deng Y; Feng W; Huang L; Liu H; Lin J; Zhang C; Fan Y; Liu L
Cancer Sci; 2021 May; 112(5):1785-1797. PubMed ID: 33788346
[TBL] [Abstract][Full Text] [Related]
7. Decreased CCDC19 is correlated with unfavorable outcome in lung squamous cell carcinoma.
Wang Y; Liu Z; Luo R; Xie Y
Int J Clin Exp Pathol; 2018; 11(2):802-807. PubMed ID: 31938168
[TBL] [Abstract][Full Text] [Related]
8. Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
Qi W; Shao F; Huang Q
Med Sci Monit; 2017 Dec; 23():6012-6018. PubMed ID: 29257799
[TBL] [Abstract][Full Text] [Related]
9. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
Chen Y; Jiang J; Zhao M; Luo X; Liang Z; Zhen Y; Fu Q; Deng X; Lin X; Li L; Luo R; Liu Z; Fang W
Oncotarget; 2016 Jul; 7(27):41306-41319. PubMed ID: 27191497
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.
Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M
Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505
[TBL] [Abstract][Full Text] [Related]
11. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism.
Liu Z; Li X; He X; Jiang Q; Xie S; Yu X; Zhen Y; Xiao G; Yao K; Fang W
Int J Cancer; 2011 Jun; 128(11):2562-71. PubMed ID: 20715168
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
14. Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.
Liu Z; Luo W; Zhou Y; Zhen Y; Yang H; Yu X; Ye Y; Li X; Wang H; Jiang Q; Zhang Y; Yao K; Fang W
PLoS One; 2011; 6(11):e27887. PubMed ID: 22140479
[TBL] [Abstract][Full Text] [Related]
15. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
17. Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.
Liu Z; Chen C; Yang H; Zhang Y; Long J; Long X; Fang W
Proteomics; 2012 Nov; 12(22):3416-25. PubMed ID: 22997098
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
